Fungal chemoprophylaxis with fluconazole in preterm infants

José Manuel Martínez Sesmero1, Francisco José Farfán Sedano, Teresa Molina García

  • 1Department of Pharmacy, Getafe University Hospital Ctra., de Toledo km 12,500, 28905, Getafe, Madrid, Spain. mano24@ono.com

Insights

Fluconazole chemoprophylaxis is safe and well-tolerated in very low birth weight (VLBW) infants. This antifungal treatment effectively prevented fungal infections in VLBW infants, suggesting potential to reduce mortality.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Very low birth weight (VLBW) infants are highly susceptible to fungal infections.
  • Establishing effective antifungal chemoprophylaxis is crucial for improving outcomes in this vulnerable population.

Purpose of the Study:

  • To establish a fungal chemoprophylaxis protocol for VLBW infants.
  • To evaluate the safety, tolerability, and effectiveness of fluconazole in VLBW infants.

Main Methods:

  • A protocol was developed based on MEDLINE literature search (1994-2001).
  • Inclusion criteria: gestational age <28 weeks and birth weight <1500 g.
  • Fluconazole administered intravenously; pharmacotherapeutic follow-up for 1 year.

Main Results:

  • Sixteen VLBW infants were enrolled; two deaths unrelated to study drugs.
  • No significant drug interactions or fluconazole side effects were reported.
  • No fungal infections occurred in infants completing chemoprophylaxis.

Conclusions:

  • Fluconazole demonstrated excellent safety and tolerability in VLBW infants.
  • The absence of fungal infections suggests fluconazole's potential to reduce VLBW morbidity and mortality.
Abstract

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...